You position:
Home
/
/
Plusife Biotech Brings Its Revolutionary Molecular POC Solution at Medlab Middle East 2023

Plusife Biotech Brings Its Revolutionary Molecular POC Solution at Medlab Middle East 2023

  • Categories:News & Events
  • Author:PL1_2
  • Origin:
  • Time of issue:2023-02-07 17:52
  • Views:

(Summary description)

Plusife Biotech Brings Its Revolutionary Molecular POC Solution at Medlab Middle East 2023

(Summary description)

  • Categories:News & Events
  • Author:PL1_2
  • Origin:
  • Time of issue:2023-02-07 17:52
  • Views:
Information

Pluslife is excited to return to the Dubai World Trade Centre and showcase its upgraded molecular Point-of-Care (POC) solution to visitors from February 6 to 9. Visitors can attend product presentations at booth Z3.E38 to learn about the revolutionary Eight-Channel POC Molecular Analyzer, the Mini Dock Molecular Analyzer, and test kits for various respiratory diseases, STIs, and animal diseases.

 

 

Pluslife is recognized for its Next-Generation POC Molecular Systems, which offer reliable diagnostic tests to address public health challenges, including COVID-19, Flu, RSV, HPV, and more. The MiniDock Analyzer and Eight-Channel POC Molecular Analyzer are highly integrated, allowing doctors to evaluate patients' health anytime and anywhere. Results are delivered on-site within 15 to 35 minutes and the test procedure is straightforward, consisting of only three manual steps: sampling, sample mixing, and running the test. These systems are ideal for physicians who require tests that can be used in resource-limited settings, such as emergency departments, clinics, testing centers, and CDCs.

 

 

 

As borders reopen between nations, the industry's focus is gradually shifting from the COVID-19 pandemic to regional epidemics and seasonal diseases. According to the World Health Organization's report from January, influenza has caused more outbreaks in the past 23 years than any other infectious disease. Reducing the risk of infectious diseases, including influenza, has been a key part of Pluslife's mission. During the Medlab Middle East exhibition, Pluslife's sales team will share its experiences of using the RSV, SARS-CoV-2/Flu A/Flu B, and Flu A/Flu B/RSV Nucleic Acid Test Cards in community-based scenarios. Pluslife's test cards are clinically proven to perform comparably to lab PCR tests and leading international Molecular POC brands. Additionally, they can be transported and stored without a cold chain, which can significantly reduce costs. NGOs and governments have approached Pluslife for more information on cost-effective ways to enhance healthcare facilities.

 

 

 

Medlab Middle East is a valuable opportunity for Pluslife to share its latest innovations in its Molecular POC Solution and highlight its role in addressing healthcare challenges globally. Pluslife's next exhibition will be at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, from April 15 to 18.

Tel: +86-20-31703986
E-mail:

market@pluslife.com

  (Business Enquiry)

service@pluslife.com

  (After-Sales&Technical Support)

Add: 3F-Block E, Runhui Science & Technology Park, No. 18 Shenzhou RD, Huangpu District, Guangzhou, Guangdong, China

PLUSLIFE

Monday - Friday, 08:00 -20:00

Copyright © 2021 Guangzhou Pluslife Technology  Co., Ltd.  粤ICP备19038432号